Literature DB >> 32330676

Surgical management of intraventricular hemorrhage and posthemorrhagic hydrocephalus in premature infants.

Meng-Fai Kuo1.   

Abstract

Perinatal intraventricular hemorrhage (IVH) with or without development of posthemorrhagic hydrocephalus (PHH) in premature neonates may lead to severe neurological disability. Although the percentage of preterm infants developing IVH has been greatly reduced in the last three decades, increased survival of these very immature infants has meant that large IVH with subsequent PHH is still a serious unsolved problem. Early cerebrospinal fluid diversion as a temporizing measure or a permanent shunt is the treatment of choice. This review summarizes the surgical modalities, techniques, and their complications in the management of IVH and PHH in premature infants. Though there is no level-one evidence to support the superiority of any of the currently available managements in the initial treatment of PHH over others, this review aims to provide pediatric neurosurgeons a comprehensive understanding of the pros and cons of various surgical treatment modalities, focusing on the temporizing measures before the infants is heavy enough to undergo ventriculoperitoneal shunt insertion. Based on the patient's condition, the facility and man power of the institution with minimal complication rate, the pediatric neurosurgeons may choose the best initial approach for the management of IVH and PHH in premature infants.
Copyright © 2020 Chang Gung University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Case management; Intraventricular hemorrhage; Posthemorrhagic hydrocephalus; Premature infant; Preterm infant; Ventriculoperitoneal shunt

Year:  2020        PMID: 32330676      PMCID: PMC7424093          DOI: 10.1016/j.bj.2020.03.006

Source DB:  PubMed          Journal:  Biomed J        ISSN: 2319-4170            Impact factor:   4.910


The basic anatomic structure of the germinal matrix (GM) of the premature infants may predispose them to intraventricular hemorrhage (IVH). The veins in this region make a 180° turn at the caudate nuclei and drain via internal cerebral veins. This anatomical arrangement may predispose to turbulence in blood flow and promotes platelet aggregation and vascular instability. In infants of less than 28 weeks gestation, the hemorrhage tends to occur in the head of the caudate nucleus. In full-tem infants, the choroid plexus is more likely to be the location of hemorrhage [1,2]. In premature infants, the periventricular capillaries appear as immature vascular rete, and the germinal matrix has both a gelatinous consistency and a high fibrinolytic activity. These vascular natures also play an important role in the development of IVH, which leads to a disruption in the cerebrospinal fluid (CSF) and ventricular dilatation. It is well known that 40–50% of hydrocephalus cases in premature infants, occur following GM hemorrhage (GMH). Such hemorrhages are reported to arise commonly among infants with <1500 g birth weight and <32 weeks old. Of the premature infants with IVH, 20%–50% will go on to develop ventriculomegaly, either transient or progressive. Although survival for extremely low gestational age newborns has improved in the past three decades, the continued improvements in neonatal intensive care, the survival of infants including those that develop post-hemorrhagic hydrocephalus (PHH) continues to be a challenge to the pediatric neurosurgeons [3]. This review will discuss the surgical management of IVH and PHH in the preterm infants and aims to provide neurosurgeons with the evidence needed to choose the best initial approach for PHH treatment, yet with minimal complication rate.

Intraventricular hemorrhage in premature infants

Clinical features

The premature IVH can present as a catastrophic event, saltatory, or as a clinical silent phenomenon. It usually occurs within 48 h of birth and 50% will occur in the first 24 h. A later onset is not uncommon, especially following a secondary hypoxic insult such as pneumothorax. Catastrophic deterioration evolves in minutes to hours. Aggressive neurosurgical intervention is rarely considered as many of these infants do not survive this event. The saltatory or subacute presentation is seen principally in an infant with a smaller hemorrhage that evolves over hour to days. There may be a subtle change in the decreased alertness and activity, hypotonia, abnormally tight popliteal angle, abnormal eye movements, and respiratory difficulties. Many IVHs are clinically silent and is one diagnosed by cranial ultrasonography. An unexplained decline in the hematocrit, decreased tone and activity may suggest that an IVH has occurred [4].

Management of IVH

The incidence of IVH in premature infants who weigh less than 1500 g decreased from 35%–70% to 15%–20% in the past three decades [5,6]. Less than half of these children will develop transient or progressive ventriculomegaly. Considerable ventriculomegaly can occur before any increase in intracranial pressure (ICP) or head circumference is noted. It seems reasonable to treat IVH aggressively; however, too-aggressive therapy may change a small lesion to a large one. We suggest early consultation with pediatric neurosurgeon as early as possible when premature IVH with more than a subependymal hemorrhage or mild progression of ventricular dilatation is diagnosed.

Pharmacological treatment

In the acute hemorrhage maintaining cerebral perfusion and ICP may be undertaken medically by decreasing the PaCO2, and perhaps using some medicine. However, a large multicenter randomized trial showed that reduction of CSF production by acetazolamide and furosemide had a worse outcome in the treated arm [3].

Drainage, irrigation, and fibrinolytic therapy (DRIFT)

Based on the hypothesis that reducing pressure, free iron, and proinflammatory and profibrotic cytokines may reduce death and severe disability, prevention of PHH in newborn infants by DRIFT has been conducted in UK since 2003. A total of 77 premature babies with IVH were studied. Though DRIFT improves cognitive function in the 52 out of the 66 surviving babies after 10-year follow-up, secondary IVH is a major complication that up to 35% of the infants who received DRIFT had secondary IVH compared with 8% of the standard group. In addition, DRIFT did not reduce shunt surgery or death when tested in a multicenter, randomized trial in UK. DRIFT is still not a standard treatment for the prematurity with IVH [3,[7], [8], [9]].

Neuroendoscopic lavage

A study demonstrated that neuroendoscopic lavage in 19 neonates with IVH had less shunt, fewer infections, and multiloculated hydrocephalus than the 10 neonates treated with various conventional modalities. A multicenter, prospective study to verify the outcome is warranted [10].

Management of post-hemorrhagic hydrocephalus (PHH)

Transient or progressive ventricular dilatation is seen in 20%–50% patients with premature IVH. Early ventriculoperitoneal (VP) shunt insertion is associated with a high failure rate and many complications in premature infants with PHH; hence, temporizing measures are always instituted until the infant is mature enough at age and/or weight. Many different approaches have been taken to achieve temporary ventricular decompression in infants with PHH [11]. Therapeutic serial lumbar and ventricular tapping remain temporizing options in the treatment of PHH used by 10% and 30% of the neonatal units.

Serial lumbar punctures

Lumbar puncture (LP) is only useful when the ventricles are in communication with the lumbar subarachnoid space [3]. Daily LPs can be used if it is necessary to stabilize the head circumference, and usually up to 10 ml of CSF is removed per LP [4]. It is often difficult to remove sufficient quantities of CSF in these infants, and, again, the child is exposed to contamination each time. Spinal osteomyelitis has been associated with repeated LPs [12]. It has been suggested that daily LPs need to occur for at least 7 days to be effective whereas the repeated procedures can be traumatic for the premature infants and, therefore, not always the preferred treatment. Randomized controlled trials have failed to demonstrate a significant effect of serial LPs on the rates of morbidity, mortality or conversion to permanent VP shunt in the treatment of PHH [[13], [14], [15], [16]]. Lumbar tappings are also associated with increased risk of CSF infection [17]. Hence, early repeated LPs cannot be recommended as the mainstay treatment for neonates at risk of, or actually developing PHH and spinal taps are increasingly considered a temporizing measure in the management of PPH only for an initial period. If frequent multiple LPs are needed other measures can be used as described below [18].

Serial ventricular punctures

Repeated ventricular taps incur a new injury to the frontal lobe with each pass of a needle (“puncture porencephaly”). Each access exposes the child to the risk of infection. Ventricular taps have fallen out of favor due to the risk of porencephalic cyst formation, infection, and loculated hydrocephalus [4,19]. In general, ventricular puncture should be reserved for treating infants in extremis.

Temporary devices

Most of the temporary devices which include external ventricular drainage (EVD), ventriculosubgaleal shunt (VSGS), and ventricular access device (VAD) can be performed at the bedside with or without anesthesia. However, with the advancement of neonatal neurocritical care and anesthesiology the role of beside surgery of PHH became less significant considering the higher infection rate in the neonatal unit than in the operation theater. The three temporary measures involve ventriculostomy. During cannulation of the frontal horn, Kocher's point is landmarked as a point of entry through the frontal bone for an intraventricular catheter to drain CSF. In adult or children, it is located 2.5–3 cm lateral to the midline (at approximately the mid-pupillary line) and approximately 1 cm anterior to the coronal suture. In premature infants, because of small head size, the Kocher's point is located 1.5–2 cm lateral to the midline and approximately 0.5–1 cm anterior to the coronal suture. The distance and depth can be measured accurately by preoperative bedside ultrasound. In addition, since the fontanel is widely open in premature infants with PHH, it is suggested to draw an imaginary line between the bilateral edges of the fontanel as the future coronal suture, then the Kocher's point can be properly located [Fig. 1]. Mostly, the non-dominant, right frontal horn is preferred unless the right side is not suitable to use due to any reason.
Fig. 1

(A) The Kocher's point for a proper frontal entry of the ventricular catheter is sometimes hard to locate due to the widely open fontanel in premature infant and the inexperienced neurosurgeons. In premature infants with PHH, it is suggested to draw an imaginary line between the bilateral edges of the fontanel as the future location of the coronal suture (dotted line), then the Kocher's point can be properly located (bold arrow). The Kocher's point is located 1.5–2 cm lateral to the midline and approximately 0.5–1 cm anterior to the coronal suture. (B) This patient was referred to the author from other institution due to repeated malfunction of the ventricular reservoirs and recurrent hydrocephalus. The old incisions for bilateral ventricular reservoir placement were located too anteriorly to the Kocher's point (circles). The baby just underwent a burr-hole typed ventriculoperitoneal shunt insertion after the body weight was good enough.

(A) The Kocher's point for a proper frontal entry of the ventricular catheter is sometimes hard to locate due to the widely open fontanel in premature infant and the inexperienced neurosurgeons. In premature infants with PHH, it is suggested to draw an imaginary line between the bilateral edges of the fontanel as the future location of the coronal suture (dotted line), then the Kocher's point can be properly located (bold arrow). The Kocher's point is located 1.5–2 cm lateral to the midline and approximately 0.5–1 cm anterior to the coronal suture. (B) This patient was referred to the author from other institution due to repeated malfunction of the ventricular reservoirs and recurrent hydrocephalus. The old incisions for bilateral ventricular reservoir placement were located too anteriorly to the Kocher's point (circles). The baby just underwent a burr-hole typed ventriculoperitoneal shunt insertion after the body weight was good enough.

External ventricular drainage (EVD)

The chances of infection and the long duration required for EVD make it an unattractive option. The EVD procedures were performed with a ventricular catheter connected to a closed drainage plastic container via subcutaneous tunneling. EVD has the physiological advantage of continuous clearance of bloody CSF [20,21]. Therefore, EVD reduces the spikes of intracranial hypertension which can occur with intermittent tapping. It also gives an opportunity to titrate the amount of CSF drained in order to prevent problems of underdrainage. On the contrary, the continuous drain may induce overdrainage and results in trapped and loculated ventricle. Considering the small amount of CSF, 10 mL/kg/day, that needs to be drained in premature infants with PHH [21], the advantage of continuous drainage of EVD becomes less significant. The disadvantages of EVD include infection, need for repeated CSF studies, and repeated rotation of the EVD site, obstruction and dislodgement of the catheter, and CSF leakage from the exit site of EVD. Though a long-segment of EVD can be performed to reduce infection and to reduce rotation of the EVD site, EVD is not a favored way to manage PHH in pediatric neurosurgery [11,[22], [23], [24]].

Ventriculosubgaleal shunt (VSGS)

Since the first VSGS was performed in 1896 by von Mikulicz, VSGS has been used in chronic postoperative CSF fistulas, tumor, recurrent subdural hematoma, acute head trauma, and repeated VP shunt infections [[25], [26], [27], [28], [29], [30], [31], [32]]. A VSGS consists of a shunt tube with one end in the lateral ventricle while the other end is inserted into the subgaleal space of the scalp. This will allow for the membranes of the scalp to absorb the excess CSF [Fig. 2]. VSGS is preferred by many institutions because it is a simple and rapid method, precludes the need for repeated aspiration without causing electrolyte and nutritional losses. VSGS is associated with lower infection rates than EVD due to the closed system of CSF drainage and lack of external tubes.
Fig. 2

The cartoon shows the ventriculosubgaleal shunt. The ventricular catheter can be connected to a subgaleal catheter with a right-angle connector or a low-pressure valve (not shown). A one-way mechanism is needed by using a subgaleal catheter with slits or a low-pressure valve.

The cartoon shows the ventriculosubgaleal shunt. The ventricular catheter can be connected to a subgaleal catheter with a right-angle connector or a low-pressure valve (not shown). A one-way mechanism is needed by using a subgaleal catheter with slits or a low-pressure valve.

Surgical techniques of VSGS

It is important to identify the coronal sutures and locate the Kocher's point for the entrance of ventricular catheter [Fig. 1]. Other important factor includes not grasping the extremely thin skin of the premature infants during the whole procedure [Fig. 3]. In the supine position, the first step is placement of a ventricular catheter into the frontal horn. Next, the ventricular catheter is connected to either a reservoir or via a right angled connector to a short piece of close-end tubing with slits on it in order to establish one-way flow from the ventricle into the subgaleal pocket. If a reservoir is not used, the tubing is secured to the periosteum with suture to prevent catheter migration into or out of the lateral ventricle. To prevent this, the use of a reservoir is suggested. A subgaleal pocket is formed with blunt dissection with finger sweep or blunt tipped Metz scissors with curved ends. In the latter case, care must be given to dissecting the subgaleal space and not a more superficial or deeper layer. Since larger subgaleal pockets can prolong the longevity of the VSGS, always try to dissect out laterally toward each ear, posteriorly over the occiput, not onto the forehead taking care when crossing the midline and avoid button holing the skin. The subgaleal catheter is situated to drain in the direction of the pocket. The wound is closed in two layers.
Fig. 3

A non-grasping technique is used during the whole shunting procedure in premature infants to prevent skin injury. The two arms of a forceps can be used as retractor to separate the incision and prevent injury to the thin skin.

A non-grasping technique is used during the whole shunting procedure in premature infants to prevent skin injury. The two arms of a forceps can be used as retractor to separate the incision and prevent injury to the thin skin.

Longevity (survival duration) and evaluation of the effectiveness of VSGS

The average longevity of the primary VSGS was 35.1 and 37.4 days, respectively in two studies. Some of the infants may need two VSG shunts [19,33]. The survival duration of the VSGS is variable depending on several factors that include the absorptive capacity of the subgaleal space and the creation of an ample space during dissection. However, in some cases the ventricles might re-enlarge due to the large collection of CSF exceeding the absorptive capacity of the subgaleal space. This is an indication for a shunt conversion [34]. The effectiveness of VSGS is judged by reduction of head circumference, softening of the anterior fontanel, and reduction of ventricular size as seen on cranial ultrasound or other neuroimaging studies. In cases of VSGS failure, either the previously soft, fluctuant subgaleal pocket became tense with fluid, or the subgaleal space became obliterated without the presence of subgaleal fluid. Cranial imaging confirm ventricular enlargement with either scenario.

Complications of VSGS

The drawback of VSGS is the cosmetically unappealing swelling caused by the CSF collection in the subgaleal space [22]. Most of the parents accept the transient cosmetic problem if they are made aware of the significant scalp swelling. The complications of VSGS include wound leakage before or when sutures were removed, kinking and blockage of the catheter, migration of the catheter from the ventricle or its slippage into the lateral ventricle, VSGS-related death due to intraoperative rapid decompression of a poorly myelinated neonatal brain under high pressure, resulting in numerous intracerebral hemorrhages [19]. In a study of Willis et al., a unacceptably high infection rate of VSGS was noted that even made VSGS no longer performed at their institution. The infection includes infection of VSGS per se, and 3/4 of the infections occurred after the VSGS were converted to a VP shunt [22]. They proposed the cause of infection as below: the formation of pseudomeningocele in the subgaleal space causes further thinning of the extremely thin skin of the premature infants promoting colonization by skin flora. They suggested CSF sampling before conversion VSGS to a permanent shunt and changes in the proximal hardware (ventricular catheter and the valve) of VSGS at the time of insertion of the VP shunt, as the VSG shunts have been in situ for a prolonged period in contact with potentially colonized CSF, may decrease the infection rates [22]. In most of the VSGS complications, the shunts needed to be removed. Another rare, potential complication of VSGS is the secondary subgaleal encephaloceles that resulted in seizure, meningitis, abscess formation, and infarction of herniated brain parenchyma [35] [Fig. 4]. The other unique complications of VSGS include the requirement of CSF taps shortly before a permanent VP shunt is placed when CSF absorption from the subgaleal pocket is no longer adequate to control the hydrocephalus and severe skull deformity [36]. It should be noted that infants should have their head turned every couple of hours in order to avoid skull deformation, which can be severe.
Fig. 4

A rare but unique complication of VSGS, the secondary subgaleal encephaloceles that has to be recognized, especially when the patient has unusual presentation of seizure, meningitis, abscess formation, and infarction of herniated brain parenchyma.

A rare but unique complication of VSGS, the secondary subgaleal encephaloceles that has to be recognized, especially when the patient has unusual presentation of seizure, meningitis, abscess formation, and infarction of herniated brain parenchyma.

Ventricular access device (VAD), subcutaneous ventricular reservoir, neonatal reservoir, Ommaya reservoir [Fig. 5]

One of the most acceptable forms of temporized drainage for the prematurity is the implantation of VADs, which located in subgaleal space are repeatedly tapped for decompression of intracranial hypertension and antibiotic and fibrinolytic agents are administered via the reservoir if needed [37]. It also allows easy conversion to a permanent shunt as the suitable proximal hardware is already in place [22]. The drawback of VAD is the need for repeated punctures of the reservoir with an additional risk of infection though it is much less than that of EVD. Other drawbacks include labor-intensive, wound problems, occlusion, not providing constant decompression of the ventricles, and the loss of protein- and electrolyte-laden CSF [[37], [38], [39]]. In the author's institution, a tertiary medical center, VAD is routinely used as the first choice in PHH with minimal complications. A ventricular catheter with integrated reservoir (CSF ventricular reservoir, Medtronic Inc.) from one of the many manufactures. The intracranial length of 3.5 to 4 cm is most commonly used in premature infants.

Surgical techniques of neonatal reservoir [Fig. 6]

The right frontal and parietal regions are shaved and prepped. The skin just anterior to the coronal suture and over the parietal bone is infiltrated with normal saline. The frontal part is for the entrance of ventricular catheter and the parietal part is for the placement of the subcutaneous reservoir. A linear or semi-lunar incision is made anterior to the Kocher's entry point, so that the ventricular catheter later placed does not erode through the incision line. The coronal suture is confirmed again then the dura over the Kocher's point is coagulated with a bipolar unit and incised. The subgaleal space over the parietal bone is dissected bluntly, then the reservoir dome is placed underneath the skin. The ventricular catheter is inserted into the right lateral ventricle, the incision is then closed in two layers. A 27-gauge needle is used to confirm the function of the reservoir by aspiration of the CSF smoothly. The photo shows the proper setting of the ventricular access device (VAD). The patient is going to receive the conversion of a temporizing VAD to a ventriculoperitoneal shunt.

Treatment protocol of VAD

The reservoir is tapped through the scalp on a regular basis to remove CSF and maintain a stable clinical condition which includes normal increase of head circumference, soft fontanel, and sonogram. In the supine position, a scalp needle of 25-gauge or a smaller one is used to tap the reservoir. The frequency and amount of CSF aspiration is tailored for each infant and is determined by the opening and closing pressures, respectively. When the infant lies in supine position, the water-level of the scalp needle at the forehead level is about 3 cm of intraventricular pressure. Since the normal intraventricular pressure of the premature infant is subatmospheric, we aspirate the CSF of an amount till the closing pressure is just below the level of the forehead. While we like to keep the opening pressure lower than 8 cm, which is the upper limit of the normal ICP of full-term infants. If the opening pressure is higher than 8 cm, the frequency of tapping is increased, for example from once daily to twice daily. It is better to keep the ventricle system mild dilated than collapsed and anterior fontanel soft than marked depressed. Sonograms can be used to confirm the ventricular size. If the frequency of tapping can be tapered according to the lowering of opening pressure, decreasing amount of CSF in each tap, and the symptomatic hydrocephalus dissipates, the reservoir may be no longer needed. In this situation, we do not routinely remove the VAD or we will wait for at least four years if the parents insist to have it removed. If it becomes evident that permanent CSF diversion is necessary, the VAD will be converted to VP shunt when the baby's weight or age is good enough.

Comparison between the temporary measures (Table 1)

The rates of VP shunt requirement and device infection were similar between patients treated with VAD versus the VSGS [40]. The VSGS requires less labor-intensive management by ventricular tapping; the VSGS patients also attained higher weights and more optimal surgical candidacy at the time of VP shunt insertion. However, some complications are unique to VSGS, it is thus important for the treating physicians to be aware of these rare, potential complications while using VSGS in the management of PHH. Finally, the potential differences in long-term developmental and neurological outcomes between VSGS and VAD warrant further study [40]. Comparison between different temporary measures. Abbreviations: EVD: external ventricular drainage; VSGS: ventriculosubgaleal shunt; VAD: ventricular access device.

Permanent surgical management

VP shunt

Early VP shunt insertion is associated with a high failure rate and many complications; hence, temporizing measures are always instituted until the infant is mature (age and/or weight) enough [18]. VP shunting is indicated when the ventricles continue to enlarge at a body weight exceeds 2 kg and CSF protein levels are below 1–1.5 g/L, then VP shunt insertion is appropriate [3]. Though these minimal requirements are subjective, they indicate fewer complications [22,41].

Endoscopic third ventriculostomy (ETV)

ETV offers an alternative to a shunt in selected patients with obstructive hydrocephalus; however, ETV alone has low success rate for premature infants with PHH because the age and cause of hydrocephalus of these infants are unfavorable factors of a successful ETV [42]. Combined ETV and choroid plexus cauterization may be effective on the treatment of a selected subsets of premature infants with PHH though further study is warranted [43].

Discussion

Significant progress has been made to reduce neonatal mortality, and neurological complication of prematurity. Although it is likely that fewer premature infants will suffer IVH in the future, the treatment, reduction of perioperative complications and surgical outcome of IVH in premature infants remain challenging to pediatric neurosurgeons. This review aims to provide pediatric neurosurgeons a comprehensive understanding of various surgical treatment modalities, focusing on the temporizing measures before the infants is heavy and old enough to undergo permanent surgical management. The pediatric neurosurgeons may choose the best initial approach for the management of IVH and PHH in premature infants based on the facility and man power of the institution and the evidence of previous studies. A successful transition from the temporizing measures to permanent shunt insertion or resolution of hydrocephalus with minimal perioperative complication is the key to a good surgical outcome of these premature infants with IVH and PHH.

Conflict of interest

Authors have declared that no competing interests exist.
Table 1

Comparison between different temporary measures.

EVDVSGSVAD
Close system++
Continuous drainage+± or +
Repeated aspiration+
Labor intense++++
Risk of over-drainage or under-drainage++
Electrolyte and nutritional loss++
Risk of infection++++
CSF studies before conversion to a permanent shunt+++++
Changes of the hardware when converting to a permanent shunt++++++±
Survival durationShortAverage 30 daysLong
Unique complications and drawbacksCatheter migration, unappealing scalp swelling, skull deformity, secondary subgaleal encephalocele

Abbreviations: EVD: external ventricular drainage; VSGS: ventriculosubgaleal shunt; VAD: ventricular access device.

  41 in total

Review 1.  Ventriculosubgaleal shunting-a comprehensive review and over two-decade surgical experience.

Authors:  Seif Eid; Joe Iwanaga; Rod J Oskouian; Marios Loukas; W Jerry Oakes; R Shane Tubbs
Journal:  Childs Nerv Syst       Date:  2018-07-12       Impact factor: 1.475

Review 2.  Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment concepts.

Authors:  Shenandoah Robinson
Journal:  J Neurosurg Pediatr       Date:  2012-03       Impact factor: 2.375

3.  Ventriculosubgaleal shunts for posthemorrhagic hydrocephalus in premature infants.

Authors:  Brian K Willis; Cherukuri Ravi Kumar; Esther L Wylen; Anil Nanda
Journal:  Pediatr Neurosurg       Date:  2005 Jul-Aug       Impact factor: 1.162

4.  Secondary pediatric encephalocele after ventriculosubgaleal shunting for posthemorrhagic hydrocephalus.

Authors:  Daniel Seeburg; Edward Ahn; Thierry Huisman
Journal:  Neuropediatrics       Date:  2013-12-19       Impact factor: 1.947

5.  Pathogenesis of intraventricular hemorrhage.

Authors:  G Hambleton; J S Wigglesworth
Journal:  J Pediatr       Date:  1979-01       Impact factor: 4.406

6.  Ventriculo-subgaleal shunt: evaluation by computed tomography.

Authors:  A J Drapkin; M E Levine; W C Yang
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

7.  Ten-year follow-up of a randomised trial of drainage, irrigation and fibrinolytic therapy (DRIFT) in infants with post-haemorrhagic ventricular dilatation.

Authors:  Karen Luyt; Sally Jary; Charlotte Lea; Grace J Young; David Odd; Helen Miller; Grazyna Kmita; Cathy Williams; Peter S Blair; Aída Moure Fernández; William Hollingworth; Michelle Morgan; Adam Smith-Collins; N Jade Thai; Steven Walker-Cox; Kristian Aquilina; Ian Pople; Andrew Whitelaw
Journal:  Health Technol Assess       Date:  2019-02       Impact factor: 4.014

8.  Outcome for preterm infants with germinal matrix hemorrhage and progressive hydrocephalus.

Authors:  M L Levy; L S Masri; J G McComb
Journal:  Neurosurgery       Date:  1997-11       Impact factor: 4.654

9.  Epidural abscess and vertebral osteomyelitis following serial lumbar punctures.

Authors:  I Bergman; E R Wald; J D Meyer; M J Painter
Journal:  Pediatrics       Date:  1983-10       Impact factor: 7.124

10.  Ventriculosubgaleal shunt procedure and its long-term outcomes in premature infants with post-hemorrhagic hydrocephalus.

Authors:  Vaner Köksal; Suat Öktem
Journal:  Childs Nerv Syst       Date:  2010-03-19       Impact factor: 1.475

View more
  5 in total

1.  Does ventricle size contribute to cognitive outcomes in posthemorrhagic hydrocephalus? Role of early definitive intervention.

Authors:  Mounica Paturu; Regina L Triplett; Siddhant Thukral; Dimitrios Alexopoulos; Christopher D Smyser; David D Limbrick; Jennifer M Strahle
Journal:  J Neurosurg Pediatr       Date:  2021-10-15       Impact factor: 2.713

2.  Protecting the blossoming brain - Neurocritical care in children.

Authors:  Sophia Julia Häfner
Journal:  Biomed J       Date:  2020-06-14       Impact factor: 4.910

3.  Recent update in pediatric neurocritical care: Preface.

Authors:  Huei-Shyong Wang
Journal:  Biomed J       Date:  2020-05-23       Impact factor: 4.910

Review 4.  Germinal Matrix-Intraventricular Hemorrhage: A Tale of Preterm Infants.

Authors:  Walufu Ivan Egesa; Simon Odoch; Richard Justin Odong; Gloria Nakalema; Daniel Asiimwe; Eddymond Ekuk; Sabinah Twesigemukama; Munanura Turyasiima; Rachel Kwambele Lokengama; William Mugowa Waibi; Said Abdirashid; Dickson Kajoba; Patrick Kumbowi Kumbakulu
Journal:  Int J Pediatr       Date:  2021-03-16

5.  Posthemorrhagic hydrocephalus associates with elevated inflammation and CSF hypersecretion via activation of choroidal transporters.

Authors:  Sara Diana Lolansen; Nina Rostgaard; Dagne Barbuskaite; Tenna Capion; Markus Harboe Olsen; Nicolas H Norager; Frederik Vilhardt; Søren Norge Andreassen; Trine L Toft-Bertelsen; Fenghui Ye; Marianne Juhler; Richard F Keep; Nanna MacAulay
Journal:  Fluids Barriers CNS       Date:  2022-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.